Similar Items: Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa
- Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
- Cost Impact of a Novel Pre-transplant Risk Assessment Tool for Early Acute Rejection in Kidney Transplant Patients
- Digital Assistive Technology Acceptance and Use by Caregivers of Older Adults With Cognitive Impairment: Qualitative Interview Study
- Primary Care Cost Sharing in Medicare Advantage